In this increasingly cost-conscious drug development and commercialisation environment, value is at the forefront of the minds of patients, payers, HCP's, and policymakers.
ICON's Access, Commercialisation & Communications (ACC) integrated team of industry experts provide life-science clients with strategic guidance and workable tactical solutions to support commercial success around the globe. ACC’s seamless integration of pricing, HEOR, publication/value communication, reimbursement, market access, HTA, patient insights and creative services efficiently delivers cross-functional customized solutions that drive the commercial success of our clients’ products.